Journal of Tuberculosis and Therapeutics
Open Access
Pulmonary Tuberculosis
Search results for
Pulmonary Tuberculosis
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Useful Links
Related Subjects
Share This Page
Pulmonary Tuberculosis
It occurs to the upper lobe of the right lung. Mycobacterium grow at high levels of oxygen and blood thus it effects lungs, and later on passes to other part of the body called as extrapulmonary tuberculosis. It is potentially deadly disease but it can be cured by medical help. Most of the people recover with primary TB. The infection may stay inactive for years, and it may become active again.
Pulmonary Tuberculosis
Expert PPTs
- Haider Abdul-Lateef Mousa
viral infections
PPT Version | PDF Version - Sharifi Mood
Infectious Diseases
PPT Version | PDF Version
Speaker PPTs
- Shoude Jin
Mechanisms of Chronic obstructive pulmonary disease and airway smooth muscle remodeling: the potential roles of Abhd2
| PDF Version - Alsayed Alnahal
Urinary netrin-1 predict early ischemic acute kidney injury after cardiopulmonary bypass
PPT Version | PDF Version - Ping Yang
Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
| PDF Version - Gunilla Lindqvist
Chronic obstructive pulmonary disease: A study of the relationship between patientsââ¬â¢ feeling of guilt due to their belief of the disease being self inflicted
| PDF Version - Roger Mark Engel
The effect of including manual therapy in the management of mild chronic obstructive pulmonary disease ââ¬â a randomized controlled trial
| PDF Version - Rupal Patel Mansukhani
Correlation of Medication Therapy in Chronic Obstructive Pulmonary Disease(COPD) Patients with 30-day Readmission Rates
PPT Version | PDF Version - Zakaria Hmama
A non-genetic approach to improve the tuberculosis vaccine BCG
PPT Version | PDF Version - Hadeel Faisal Gad
In-vitro analysis of cytokines responses of visceral leishmaniasis and pulmonary tuberculosis patients to homologous and heterologous antigen stimulation
PPT Version | PDF Version - Rinat Islamov
Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
PPT Version | PDF Version - Akujobi Comfort
Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
PPT Version | PDF Version - Helmi Mardassi
A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
PPT Version | PDF Version - Xin Wang
IL17 Pathway Involves Moderating Pulmonary Hypertension, a common complication of COPD, in Statins Therapy in Smoking Rats
PPT Version | PDF Version - Takalani Tshitangano
The management of health care workersââ¬â¢ latent tuberculosis infection at hospitals of Vhembe district
PPT Version | PDF Version - Abu Salim Mustafa
Diagnostic potential of M. tuberculosis-specific proteins and peptides
PPT Version | PDF Version - Syed Khajamohiddin
Engineering of cytochrome P450 monooxygenases-based novel inhibitors against Mycobacterium tuberculosis
PPT Version | PDF Version